Search Results - "Hankey, Graeme J."

Secondary stroke prevention by Hankey, Graeme J, Prof

“…Summary Survivors of stroke and transient ischaemic attacks are at risk of a recurrent stroke, which is often more severe and disabling than the index event…”
Get full text

Nutrition and the risk of stroke by Hankey, Graeme J, Prof

“…Summary Poor nutrition in the first year of a mother's life and undernutrition in utero, infancy, childhood, and adulthood predispose individuals to stroke in…”
Get full text

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study by O'Donnell, Martin J, Dr, Xavier, Denis, Prof, Liu, Lisheng, Prof, Zhang, Hongye, Prof, Chin, Siu Lim, Rao-Melacini, Purnima, MSc, Rangarajan, Sumathy, MSc, Islam, Shofiqul, MSc, Pais, Prem, Prof, McQueen, Matthew J, Prof, Mondo, Charles, MD, Damasceno, Albertino, Prof, Lopez-Jaramillo, Patricio, Prof, Hankey, Graeme J, Prof, Dans, Antonio L, Prof, Yusoff, Khalid, Prof, Truelsen, Thomas, DMSc, Diener, Hans-Christoph, Prof, Sacco, Ralph L, Prof, Ryglewicz, Danuta, Prof, Czlonkowska, Anna, Prof, Weimar, Christian, Prof, Wang, Xingyu, Prof, Yusuf, Salim, Prof

“…Summary Background The contribution of various risk factors to the burden of stroke worldwide is unknown, particularly in countries of low and middle income…”
Get full text

The benefits of aspirin in early secondary stroke prevention by Hankey, Graeme J

“…Aspirin is considered an affordable and widely available, if only modestly effective, thromboprophylactic for secondary stroke prevention. The two large…”
Get full text

Hearing loss and the risk of dementia in later life by Ford, Andrew H., Hankey, Graeme J., Yeap, Bu B., Golledge, Jonathan, Flicker, Leon, Almeida, Osvaldo P.

“…•Hearing loss is a potentially modifiable risk factor for dementia.•In our cohort, men with hearing loss had a 69% greater hazard of developing dementia than…”
Get full text

Guideline for the diagnosis and management of hypertension in adults — 2016 by Gabb, Genevieve M, Mangoni, Arduino A, Anderson, Craig S, Cowley, Diane, Dowden, John S, Golledge, Jonathan, Hankey, Graeme J, Howes, Faline S, Leckie, Les, Perkovic, Vlado, Schlaich, Markus, Zwar, Nicholas A, Medley, Tanya L, Arnolda, Leonard

“…Summary The National Heart Foundation of Australia has updated the Guide to management of hypertension 2008: assessing and managing raised blood pressure in…”
Get full text

B vitamins for stroke prevention by Hankey, Graeme J

“…Supplementation with B vitamins (vitamin B9(folic acid), vitamin B12 and vitamin B6) lowers blood total homocysteine (tHcy) concentrations by about 25% and…”
Get full text

Intracranial Hemorrhage and Novel Anticoagulants for Atrial Fibrillation: What Have We Learned? by Hankey, Graeme J.

“…Intracranial hemorrhage (ICH) affects 0.2-0.5 % of atrial fibrillation (AF) patients taking a novel oral anticoagulant (NOAC) each year. About two thirds of…”
Get full text

The global and regional burden of stroke by Hankey, Graeme J

Get full text

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery by Mead, Gillian E, Hsieh, Cheng-Fang, Lee, Rebecca, Kutlubaev, Mansur A, Claxton, Anne, Hankey, Graeme J, Hackett, Maree L

“…Stroke is the major cause of adult disability. Selective serotonin reuptake inhibitors (SSRIs) have been used for many years to manage depression. Recently,…”
Get more information

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery by Legg, Lynn A, Tilney, Russel, Hsieh, Cheng-Fang, Wu, Simiao, Lundström, Erik, Rudberg, Ann-Sofie, Kutlubaev, Mansur A, Dennis, Martin, Soleimani, Babak, Barugh, Amanda, Hackett, Maree L, Hankey, Graeme J, Mead, Gillian E

“…Stroke is a major cause of adult disability. Selective serotonin reuptake inhibitors (SSRIs) have been used for many years to manage depression and other mood…”
Get more information

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery by Legg, Lynn A, Rudberg, Ann-Sofie, Hua, Xing, Wu, Simiao, Hackett, Maree L, Tilney, Russel, Lindgren, Linnea, Kutlubaev, Mansur A, Hsieh, Cheng-Fang, Barugh, Amanda J, Hankey, Graeme J, Lundström, Erik, Dennis, Martin, Mead, Gillian E

“…Selective serotonin reuptake inhibitors (SSRIs) might theoretically reduce post-stroke disability by direct effects on the brain. This Cochrane Review was…”
Get more information

The longitudinal association between natural outdoor environments and mortality in 9218 older men from Perth, Western Australia by Zijlema, Wilma L., Stasinska, Ania, Blake, David, Dirgawati, Mila, Flicker, Leon, Yeap, Bu B., Golledge, Jonathan, Hankey, Graeme J., Nieuwenhuijsen, Mark, Heyworth, Jane

“…Natural outdoor environments may mitigate harmful environmental factors associated with city living. We studied the longitudinal relationship between natural…”
Get full text

Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals by Vollset, Stein Emil, Prof, Clarke, Robert, Dr, Lewington, Sarah, DPhil, Ebbing, Marta, MD, Halsey, Jim, BSc, Lonn, Eva, Prof, Armitage, Jane, Prof, Manson, JoAnn E, Prof, Hankey, Graeme J, Prof, Spence, J David, Prof, Galan, Pilar, MD, Bønaa, Kaare H, Prof, Jamison, Rex, Prof, Gaziano, J Michael, MD, Guarino, Peter, PhD, Baron, John A, Prof, Logan, Richard FA, Prof, Giovannucci, Edward L, Prof, den Heijer, Martin, MD, Ueland, Per M, Prof, Bennett, Derrick, PhD, Collins, Rory, Prof, Peto, Richard, Prof

“…Summary Background Some countries fortify flour with folic acid to prevent neural tube defects but others do not, partly because of concerns about possible…”
Get full text

Rivaroxaban for Stroke Prevention in East Asian Patients From the ROCKET AF Trial by Wong, Ka Sing Lawrence, Hu, Dai Yi, Oomman, Abraham, Tan, Ru-San, Patel, Manesh R, Singer, Daniel E, Breithardt, Günter, Mahaffey, Kenneth W, Becker, Richard C, Califf, Robert, Fox, Keith A.A, Berkowitz, Scott D, Hacke, Werner, Hankey, Graeme J

“…BACKGROUND AND PURPOSE—In Rivaroxaban Once Daily Oral Direct Factor Xa Inhibitor Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial…”
Get full text

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF by Hankey, Graeme J, Prof, Patel, Manesh R, MD, Stevens, Susanna R, MSc, Becker, Richard C, MD, Breithardt, Günter, MD, Carolei, Antonio, Prof, Diener, Hans-Christoph, MD, Donnan, Geoffrey A, MD, Halperin, Jonathan L, Prof, Mahaffey, Kenneth W, MD, Mas, Jean-Louis, MD, Massaro, Ayrton, MD, Norrving, Bo, MD, Nessel, Christopher C, MD, Paolini, John F, MD, Roine, Risto O, MD, Singer, Daniel E, Prof, Wong, Lawrence, MD, Califf, Robert M, Prof, Fox, Keith AA, Prof, Hacke, Werner, MD

“…Summary Background In ROCKET AF, rivaroxaban was non-inferior to adjusted-dose warfarin in preventing stroke or systemic embolism among patients with atrial…”
Get full text

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) by Washam, Jeffrey B, Pharm D, Stevens, Susanna R, MS, Lokhnygina, Yuliya, PhD, Halperin, Jonathan L, Prof, Breithardt, Günter, Prof, Singer, Daniel E, Prof, Mahaffey, Kenneth W, Prof, Hankey, Graeme J, Prof, Berkowitz, Scott D, MD, Nessel, Christopher C, MD, Fox, Keith A A, Prof, Califf, Robert M, Prof, Piccini, Jonathan P, MD, Patel, Manesh R, Dr

“…Summary Background Digoxin is a widely used drug for ventricular rate control in patients with atrial fibrillation (AF), despite a scarcity of randomised trial…”
Get full text

Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial by Piccini, Jonathan P., MD, MHS, Stevens, Susanna R., MS, Lokhnygina, Yuliya, PhD, Patel, Manesh R., MD, Halperin, Jonathan L., MD, Singer, Daniel E., MD, Hankey, Graeme J., MD, Hacke, Werner, MD, PhD, Becker, Richard C., MD, Nessel, Christopher C., MD, Mahaffey, Kenneth W., MD, Fox, Keith A.A., MB, ChB, Califf, Robert M., MD, Breithardt, Günter, MD

“…Objectives This study sought to investigate the outcomes following cardioversion or catheter ablation in patients with atrial fibrillation (AF) treated with…”
Get full text

Factors Associated With Major Bleeding Events by Goodman, Shaun G., MD, MSc, Wojdyla, Daniel M., MS, Piccini, Jonathan P., MD, White, Harvey D., MB, ChB, DSc, Paolini, John F., MD, PhD, Nessel, Christopher C., MD, Berkowitz, Scott D., MD, Mahaffey, Kenneth W., MD, Patel, Manesh R., MD, Sherwood, Matthew W., MD, Becker, Richard C., MD, Halperin, Jonathan L., MD, Hacke, Werner, MD, Singer, Daniel E., MD, Hankey, Graeme J., MD, Breithardt, Gunter, MD, Fox, Keith A.A., MB, ChB, Califf, Robert M., MD

“…Objectives This study sought to report additional safety results from the ROCKET AF (Rivaroxaban Once-daily oral Direct Factor Xa Inhibition Compared with…”
Get full text

Depression, Frailty, and All-Cause Mortality: A Cohort Study of Men Older than 75 Years by Almeida, Osvaldo P., MD, PhD, Hankey, Graeme J., MD, Yeap, Bu B., MBBS, PhD, Golledge, Jonathan, MChir, Norman, Paul E., DS, Flicker, Leon, MBBS, PhD

“…Abstract Background Depression is associated with increased mortality, but it is unclear if this relationship is truly causal. Objectives To determine the…”
Get full text